171 related articles for article (PubMed ID: 20805028)
1. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
[TBL] [Abstract][Full Text] [Related]
2. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
3. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
5. Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase.
Zhang S; Chen X; Parveen S; Hussain S; Yang Y; Jing C; Zhu C
ChemMedChem; 2013 Apr; 8(4):603-13. PubMed ID: 23136050
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
Costantino L; Rastelli G; Vescovini K; Cignarella G; Vianello P; Del Corso A; Cappiello M; Mura U; Barlocco D
J Med Chem; 1996 Oct; 39(22):4396-405. PubMed ID: 8893834
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
8. Docking and molecular dynamics study on the inhibitory activity of coumarins on aldose reductase.
Wang Z; Ling B; Zhang R; Liu Y
J Phys Chem B; 2008 Aug; 112(32):10033-40. PubMed ID: 18637681
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition effect of epalrestat on rat lens osmotic expansion].
Ji LX; Shen N; Li CN; Liu Q; Huan Y; Shen ZF
Yao Xue Xue Bao; 2009 Oct; 44(10):1107-11. PubMed ID: 20055132
[TBL] [Abstract][Full Text] [Related]
10. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
[TBL] [Abstract][Full Text] [Related]
11. Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications.
Vyas B; Choudhary S; Singh PK; Kumar M; Verma H; Singh M; Malik AK; Silakari O
Bioorg Chem; 2020 Mar; 96():103570. PubMed ID: 31978681
[TBL] [Abstract][Full Text] [Related]
12. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
[TBL] [Abstract][Full Text] [Related]
13. Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex.
Petrova T; Steuber H; Hazemann I; Cousido-Siah A; Mitschler A; Chung R; Oka M; Klebe G; El-Kabbani O; Joachimiak A; Podjarny A
J Med Chem; 2005 Sep; 48(18):5659-65. PubMed ID: 16134934
[TBL] [Abstract][Full Text] [Related]
14. Phenolic marine natural products as aldose reductase inhibitors.
Manzanaro S; Salva J; de la Fuente JA
J Nat Prod; 2006 Oct; 69(10):1485-7. PubMed ID: 17067167
[TBL] [Abstract][Full Text] [Related]
15. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
[TBL] [Abstract][Full Text] [Related]
16. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
Steuber H; Heine A; Podjarny A; Klebe G
J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
[TBL] [Abstract][Full Text] [Related]
17. Ponalrestat: a potent and specific inhibitor of aldose reductase.
Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
[TBL] [Abstract][Full Text] [Related]
18. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
El-Sayed S; Metwally K; El-Shanawani AA; Abdel-Aziz LM; El-Rashedy AA; Soliman MES; Quattrini L; Coviello V; la Motta C
Bioorg Med Chem Lett; 2017 Oct; 27(20):4760-4764. PubMed ID: 28935265
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach.
Choudhary S; Silakari O
J Biomol Struct Dyn; 2022 Aug; 40(13):6052-6070. PubMed ID: 33480327
[TBL] [Abstract][Full Text] [Related]
20. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
